Phone Whasapp

Pharmed Limited. unlisted shares, Pharmed Limited. unlisted share Price, Pharmed Limited. PRE-IPO share, Pharmed Limited. upcoming ipo dealers, Pharmed stock ,Best Pharmed Limited. Unlisted Shares , top Pharmed Limited. Unlisted Shares,buy sell Pharmed Limited. shares at meera associate ,Pharmed unlisted share dealers

Pharmed Limited. Pharmed unlisted shares, Pharmed Limited. unlisted share Price, Pharmed Limited. PRE-IPO share, Pharmed Limited. upcoming ipo dealers, Pharmed Limited. stock ,Best Pharmed Limited. Unlisted Shares , top Pharmed Limited. Unlisted Shares,buy sell Pharmed Limited. shares at meera associate ,Pharmed Limited. unlisted share dealers

COMPANY NAME Pharmed Limited.D
NATURE OF BUSINESS Pharmaceutical
ISIN NO INE0EEI01017
FACE VALUE Rs.2/-
PROMOTERS Krishan Kumar Aurora
COMPANY WEBSITE www.pharmedlimited.com
YEAR OF EASTBLISHMENT 1946
REGISTERED ADDRESS Office No.21, 2nd Floor, Badheka Chambers, Manohardas Street, Fort, Mumbai - 400 001


BOARD OF DIRECTORS

Mr.Suneet Aurora (Chairman and Managing Director )
Mr.Yogesh Saran Aurora (Wholetime Director)
Mr. Kashmiri Lal Kapoor ( Wholetime Director )

Pharmed Limited India’s Health Since 1946 , headquartered in India’s Silicon Valley, Bangalore, is now one of the fastest-growing pharmaceutical companies in the country. For over seven decades, since 1946, Pharmed has been consistently carrying on its legacy of ‘Caring for India’ and helping millions of users improve quality of life.

In a journey that started over 70 years ago, Pharmed has become a name to be reckoned with among the Indian medical fraternity, with its innovative range of products that have changed disease management by enhancing lifestyle. Evidence-based pharmaceutical and nutraceutical products are at the heart of Pharmed, and are regularly promoted among Gynaecologists, Orthopaedic Surgeons, Physicians, Dermatologists and Otolaryngologists .

Companies quest to cater unmet needs across specialized therapy areas and our fervent belief in quality and innovative formulations have created opportunities for Pharmed to produce several ‘First time in India’ brands based on strong evidence. Its nationwide sales and marketing force, supported by an efficient distribution network and well-structured support departments stationed at our state-of-the-art Corporate office has made Pharmed an eminent name in the Indian Pharmaceutical Market.

Financial Analysis ( ALL IN CR )

PARTICULARS 2022-23 2021-22
REVENUE 435.97 359.64
PAT 32.97 -42.33
EPS 76.45 98.27

ANNUAL REPORT